Autoimmune Disorder

Immunology·MeSH: Autoimmune Diseases

16 drugs in development·10 companies·1 clinical trial

Drug Pipeline by Phase

Approved(3)

Drug	Company
autoimmune analyzer	Quest Diagnostics Incorporated (DGX)
Cortrophin Gel	ANI PHARMACEUTICALS INC (ANIP)
Purified Cortrophin Gel	ANI PHARMACEUTICALS INC (ANIP)

Phase 3(1)

Drug	Company
rilzabrutinib sar444671	Sanofi (SNY)

Phase 1(4)

Drug	Company
Azer-cel	TG THERAPEUTICS, INC. (TGTX)
Azercabtagene zapreleucel	TG THERAPEUTICS, INC. (TGTX)
rilzabrutinib amorphous form	Sanofi (SNY)
rilzabrutinib crystalline form	Sanofi (SNY)

Preclinical(7)

Drug	Company
AZD1656	CDT Equity Inc. (CDT)
AZD5658	CDT Equity Inc. (CDT)
gtb-7550	GT Biopharma, Inc. (GTBP)
il-2 ai synthorin	Synthorx, Inc. (THOR)
small molecule nr2f6 modulators	Regen BioPharma Inc (RGBPP)
vadc45	Vor Biopharma Inc. (VOR)
vx5	VACCINEX, INC. (VCNX)

Unknown(1)

Drug	Company
AZD1656 Cocrystal	CDT Equity Inc. (CDT)

BioSniper tracks 16 drugs in development for Autoimmune Disorder across 10 companies.

There are 1 clinical trial targeting Autoimmune Disorder tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.